In addition, NKX2-3 expression has been detected in myelodysplastic syndrome, diffuse large B-cell lymphoma, T-ALL, and T-cell lymphoma, showing its oncogenic potential in both myeloid and lymphoid cell lineages [15]. This evidence concerns the gene NKX2-3 and T-cell non-Hodgkin lymphoma.